|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global Cancer Statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lobo N, Shariat SF, Guo CC, Fernandez MI,
Kassouf W, Choudhury A, Gao J, Williams SB, Galsky MD, Taylor JA
III, et al: What is the significance of variant histology in
urothelial carcinoma? Eur Urol Focus. 6:653–663. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cheng L, Zhang S, Alexander R, Maclennan
GT, Hodges KB, Harrison BT, Lopez-Beltran A and Montironi R:
Sarcomatoid carcinoma of the urinary bladder: The final common
pathway of urothelial carcinoma dedifferentiation. Am J Surg
Pathol. 35:e34–e46. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Spiess PE, Tuziak T, Tibbs RF, Bassett R,
Tamboli P, Brown GA, Grossman HB, Ayala AG and Czerniak B:
Pseudosarcomatous and sarcomatous proliferations of the bladder.
Hum Pathol. 38:753–761. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sung MT, Wang M, MacLennan GT, Eble JN,
Tan PH, Lopez-Beltran A, Montironi R, Harris JJ, Kuhar M and Cheng
L: Histogenesis of sarcomatoid urothelial carcinoma of the urinary
bladder: Evidence for a common clonal origin with divergent
differentiation. J Pathol. 211:420–430. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sanfrancesco J, McKenney JK, Leivo MZ,
Gupta S, Elson P and Hansel DE: Sarcomatoid urothelial carcinoma of
the bladder: Analysis of 28 cases with emphasis on
clinicopathologic features and markers of epithelial-to-mesenchymal
transition. Arch Pathol Lab Med. 140:543–551. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bansal A, Kumar N and Sharma SC:
Sarcomatoid variant of urothelial carcinoma of the urinary bladder.
J Cancer Res Ther. 9:571–573. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sui W, Matulay JT, Onyeji IC, Theofanides
MC, James MB, RoyChoudhury A, Wenske S and DeCastro GJ:
Contemporary treatment patterns and outcomes of sarcomatoid bladder
cancer. World J Urol. 35:1055–1061. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Berg S, D'Andrea D, Vetterlein MW, Cole
AP, Fletcher SA, Krimphove MJ, Marchese M, Lipsitz SR, Sonpavde G,
Noldus J, et al: Impact of adjuvant chemotherapy in patients with
adverse features and variant histology at radical cystectomy for
muscle-invasive carcinoma of the bladder: Does histologic subtype
matter? Cancer. 125:1449–1458. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Almassi N, Vertosick EA, Sjoberg DD, Wong
NC, Huang C, Pietzak EJ, Cha EK, Donahue TF, Dalbagni G, Bochner
BH, et al: Pathological and oncological outcomes in patients with
sarcomatoid differentiation undergoing cystectomy. BJU Int.
129:463–469. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Advanced Bladder Cancer (ABC)
Meta-analysis Collaborators Group, : Adjuvant chemotherapy for
muscle-invasive bladder cancer: A systematic review and
meta-analysis of individual participant data from randomised
controlled trials. Eur Urol. 81:50–61. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Khaled HM, Shafik HE, Zabhloul MS, Ghoneim
M, Saber RA, Manie M, Enein HA, Megeed HA, Mansur O, Sherbini ME,
et al: Gemcitabine and cisplatin as neoadjuvant chemotherapy for
invasive transitional and squamous cell carcinoma of the bladder:
Effect on survival and bladder preservation. Clin Genitourin
Cancer. 12:e233–e240. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Williams SB, Shan Y, Jazzar U, Mehta HB,
Baillargeon JG, Huo J, Senagore AJ, Orihuela E, Tyler DS, Swanson
TA and Kamat AM: Comparing survival outcomes and costs associated
with radical cystectomy and trimodal therapy for older adults with
muscle-invasive bladder cancer. JAMA Surg. 153:881–889. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Diamantopoulos LN, Korentzelos D,
Alevizakos M, Wright JL, Grivas P and Appleman LJ: Sarcomatoid
urothelial carcinoma: A population-based study of clinicopathologic
characteristics and survival outcomes. Clin Genitourin Cancer.
20:139–147. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ding L, Bi ZF, Yuan H, Zhao XH, Guan XD,
Yao HR and Liu YM: Sarcomatoid carcinoma in the head and neck: A
population-based analysis of outcome and survival. Laryngoscope.
131:E489–e499. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park I, Cho YM, Lee JL, Ahn JH, Lee DH,
Song C, Hong JH, Kim CS and Ahn H: Prognostic factors of metastatic
renal cell carcinoma with extensive sarcomatoid component. J Cancer
Res Clin Oncol. 139:817–827. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ro JY, Ayala AG, Sella A, Samuels ML and
Swanson DA: Sarcomatoid renal cell carcinoma: Clinicopathologic. A
study of 42 cases. Cancer. 59:516–526. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang BY, Thompson RH, Lohse CM, Leibovich
BC, Boorjian SA, Cheville JC and Costello BA: A novel prognostic
model for patients with sarcomatoid renal cell carcinoma. BJU Int.
115:405–411. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Brierley JD, Gospodarowicz MK and
Wittekind C: TNM Classification of Malignant Tumours. Eighth
edition. John Wiley & Sons, Inc.; New York, NY, USA: pp.
204–207. 2017
|
|
21
|
Belsante M, Darwish O, Youssef R, Bagrodia
A, Kapur P, Sagalowsky AI, Lotan Y and Margulis V: Lymphovascular
invasion in clear cell renal cell carcinoma-association with
disease-free and cancer-specific survival. Urol Oncol.
32:30.e23–e38. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Torenbeek R, Blomjous CE, de Bruin PC,
Newling DW and Meijer CJ: Sarcomatoid carcinoma of the urinary
bladder. Clinicopathologic analysis of 18 cases with
immunohistochemical and electron microscopic findings. Am J Surg
Pathol. 18:241–249. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wright JL, Black PC, Brown GA, Porter MP,
Kamat AM, Dinney CP and Lin DW: Differences in survival among
patients with sarcomatoid carcinoma, carcinosarcoma and urothelial
carcinoma of the bladder. J Urol. 178:2302–2306; discussion 2307.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Monn MF, Kaimakliotis HZ, Pedrosa JA, Cary
KC, Bihrle R, Cheng L and Koch MO: Contemporary bladder cancer:
Variant histology may be a significant driver of disease. Urol
Oncol. 33:18.e15–18.e20. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Moschini M, Dell'Oglio P, Luciano R,
Gandaglia G, Soria F, Mattei A, Klatte T, Damiano R, Shariat SF,
Salonia A, et al: Incidence and effect of variant histology on
oncological outcomes in patients with bladder cancer treated with
radical cystectomy. Urol Oncol. 35:335–341. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Robinson SP, Farooq A, Laniado M and
Motiwala H: The demographic features, clinical outcomes, prognosis
and treatment options for patients with sarcomatoid carcinoma of
the urinary bladder: A single centre experience. Int Braz J Urol.
44:45–52. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Patel SG, Weiner AB, Keegan K and Morgan
T: Oncologic outcomes in patients with nonurothelial bladder
cancer. Indian J Urol. 34:39–44. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang J, Gillaspie C, Kunadharaju R, Talmon
GA and Enke C: Sarcomatoid urothelial carcinoma: A single cancer
center experience. World J Oncol. 2:175–180. 2011.PubMed/NCBI
|
|
29
|
Malla M, Wang JF, Trepeta R, Feng A and
Wang J: Sarcomatoid carcinoma of the urinary bladder. Clin
Genitourin Cancer. 14:366–372. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Veskimäe E, Espinos EL, Bruins HM, Yuan Y,
Sylvester R, Kamat AM, Shariat SF, Witjes JA and Compérat EM: What
is the prognostic and clinical importance of urothelial and
nonurothelial histological variants of bladder cancer in predicting
oncological outcomes in patients with muscle-invasive and
metastatic bladder cancer? A European association of urology muscle
invasive and metastatic bladder cancer guidelines panel systematic
review. Eur Urol Oncol. 2:625–642. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gu L, Ai Q, Cheng Q, Ma X, Wang B, Huang
Q, Li X, Zhang P, Liu K, Zhao X, et al: Sarcomatoid variant
urothelial carcinoma of the bladder: A systematic review and
meta-analysis of the clinicopathological features and survival
outcomes. Cancer Cell Int. 20:5502020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vetterlein MW, Wankowicz SAM, Seisen T,
Lander R, Löppenberg B, Chun FK, Menon M, Sun M, Barletta JA,
Choueiri TK, et al: Neoadjuvant chemotherapy prior to radical
cystectomy for muscle-invasive bladder cancer with variant
histology. Cancer. 123:4346–4355. 2017. View Article : Google Scholar : PubMed/NCBI
|
